Amoxi-Tabs: Product Information

AMOXI-TABS- (2s,5r,6r)-6-((r)-(-)-2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicycl(3.2.0)heptane-2-carboxylic acid trihydrate tablet, film coated
Zoetis Inc.

For use in dogs and cats

CAUTION

Federal law restricts this drug to use by or on the order of a licensed veterinarian

DESCRIPTION

Amoxi-Tabs (amoxicillin tablets) is a semisynthetic antibiotic with a broad spectrum of activity. It provides bactericidal activity against a wide range of common gram-positive and gram-negative pathogens. Chemically, it is D(-)-a-amino-p-hydroxybenzyl penicillin trihydrate.

CLINICAL PHARMACOLOGY

Amoxi-Tabs is stable in the presence of gastric acid and may be given without regard to meals. It is rapidly absorbed after oral administration. It diffuses readily into most body tissues and fluids with the exception of brain and spinal fluid, except when meninges are inflamed. Most of the amoxicillin is excreted unchanged in the urine.

Amoxicillin is similar to ampicillin in its bactericidal action against susceptible organisms. It acts through the inhibition of biosynthesis of cell wall mucopeptide. In vitro and/or in vivo studies have demonstrated the susceptibility of most strains of the following gram-positive and gram-negative bacteria: a- and b-haemolytic streptococci, nonpenicillinase-producing staphylococci, Streptococcus faecalis , Escherichia coli , and Proteus mirabilis. Because it does not resist destruction by penicillinase, it is not effective against penicillinase-producing bacteria, particularly resistant staphylococci. All strains of Pseudomonas and most strains of Klebsiella and Enterobacter are resistant

INDICATIONS AND USAGE

Dogs: Amoxi-Tabs are indicated in the treatment of susceptible strains of the organisms causing the following infections:

Respiratory tract infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus , Streptococcus spp. , E. coli , and Proteus mirabilis.

Genitourinary tract infections (cystitis) due to Staphylococcus aureus , Streptococcus spp., E. coli, and Proteus mirabilis.

Gastrointestinal tract infections (bacterial gastroenteritis) due to Staphylococcus aureus , Streptococcus spp. , E. coli , and Proteus mirabilis.

Bacterial dermatitis due to Staphylococcus aureus , Streptococcus spp. , and Proteus mirabilis.

Soft tissue infections (abscesses, lacerations,and wounds) due to Staphylococcus aureus , Streptococcus spp. , E. coli , and Proteus mirabilis.

Cats: Amoxi-Tabs are indicated in the treatment of susceptible strains of the organisms causing the following infections:

Upper respiratory tract infections due to Staphylococcus aureus , Streptococcus spp. , and E. coli.

Genitourinary tract infections (cystitis) due to Staphylococcus aureus , Streptococcus spp. , E. coli , and Proteus mirabilis.

Gastrointestinal tract infections due to E. coli.

Skin and soft tissue infections (abscesses, lacerations, and wounds) due to Staphylococcus aureus, Streptococcus spp., E. coli , and Pasteurella multocida.

As with all antibiotics, appropriate in vitro culturing and susceptibility testing of samples taken before treatment should be conducted.

CONTRAINDICATIONS

The use of this drug is contraindicated in animals with a history of an allergic reaction to penicillin.

WARNING

For use in dogs and cats only

ADVERSE REACTIONS

Amoxicillin is a semisynthetic penicillin and has the potential for producing allergic reactions. If an allergic reaction occurs, administer epinephrine and/or steroids

DOSAGE AND ADMINISTRATION

Dogs: The recommended dosage is 5 mg/lb of body weight twice a day.

Cats: The recommended dosage is 50 mg (5–10 mg/lb) once a day.

Dosage should be continued for 5–7 days or 48 hours after all symptoms have subsided. If no improvement is seen in 5 days, review diagnosis and change therapy.

Do Not Store at Temperatures Above 25°C (77°F)

Keep Bottle Tightly Closed.

HOW SUPPLIED

Amoxi-Tabs are supplied in 5 strengths: 50 mg, 100 mg, 150 mg, and 200 mg in bottles of 500 tablets; 400 mg in bottles of 250 tablets.

Approved by FDA under NADA # 055-078
Approved by FDA under NADA # 055-081
zoetis
Distributed by:
Zoetis Inc.
Kalamazoo, MI 49007
P1523357
Revised: January 2020

PRINCIPAL DISPLAY PANEL — 50 mg Tablet Bottle Label

50 mg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 mg Tablet Bottle Label

100 mg Tablet Bottle Label
(click image for full-size original)
AMOXI-TABS
amoxicillin tablet, film coated
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:54771-6042
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
(2S,5R,6R)-6-((R)-(-)-2-AMINO-2-(P-HYDROXYPHENYL)ACETAMIDO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCL(3.2.0)HEPTANE-2-CARBOXYLIC ACID TRIHYDRATE (AMOXICILLIN ANHYDROUS) AMOXICILLIN ANHYDROUS 50 mg
Product Characteristics
Color yellow Score no score
Shape ROUND Size 6mm
Flavor Imprint Code BMP193
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54771-6042-2 500 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA055081 06/02/1978
AMOXI-TABS
amoxicillin tablet, film coated
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:54771-6043
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
(2S,5R,6R)-6-((R)-(-)-2-AMINO-2-(P-HYDROXYPHENYL)ACETAMIDO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCL(3.2.0)HEPTANE-2-CARBOXYLIC ACID TRIHYDRATE (AMOXICILLIN ANHYDROUS) AMOXICILLIN ANHYDROUS 100 mg
Product Characteristics
Color blue Score no score
Shape ROUND Size 9mm
Flavor Imprint Code BMP202
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54771-6043-3 500 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA055081 06/02/1978
Labeler — Zoetis Inc. (828851555)

Revised: 06/2021 Zoetis Inc.

VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Our database mirrors the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VetLabel.com provides the full animal health subset of the FDA's repository. Veterinary information provided here is not intended as a substitute for direct consultation with a qualified veterinary professional.

Terms of Use | Copyright © 2024. All Rights Reserved.